Published by Uma Rajagopal
Posted on January 12, 2022
Future Market Insights (FMI), in its latest research study, examines the absorbable tissue spacer market and presents actionable insights on its progress over the evaluation timespan of 2019-2029. As per the research study, the global absorbable tissue spacer market reached ~US$ 85 Mn in terms of value in 2018, and is expected to propel at an impressive CAGR of ~10 % during the forecast period. Increasing emphasis of medical and healthcare industry operators on patient safety offers a strong impetus to the growth of absorbable tissue market, concludes FMI’s analysis.
Surging demand for radiation therapy in the backdrop of rising morbidities due to cancers as compared to other chronic diseases altogether in developed and under-developed economies are surfacing as the cornerstone for the progress of absorbable tissue spacer market, says the FMI study. Furthermore, stringent legal policies will persist to regulate the emission of high-energy rays during radiotherapy treatment and assure patient safety, which is likely to motivate manufacturers to perform clinical studies by consulting with experts.
Increasing prevalence of cancers continues to be a global concern, and elimination of cancerous tissues in an efficient way remains of core interest for oncologists and dosimetrists. The leading participants in absorbable tissue spacers market landscape are focusing on conducting clinical trials to develop spacers that are tailored to specific needs of the target area.
Request a report sample to obtain authentic analysis and comprehensive market insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8507
Hydrogel-based Spacer Remains Preferred among Surgeons
As per the findings of FMI’s research, hydrogel-based absorbable tissue spacers account for ~3/4th shares of total sales. The report further suggests that the hydrogel-based spacer is rapidly becoming an integral component of prostate cancer radiotherapy and is one of the few absorbable tissue spacers that have received government clearance in most of the countries.
Hydrogel-based spacers have high tolerability as the space created between prostate and rectum efficiently lowers the emission concentration on the rectum, significantly reducing irritation of rectum during prostate radiotherapy. Placing hydrogel-based spacers is technically less-complicated, especially for surgeons who are aware of ultrasound-directed transperineal injections. Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans enable confirmation about proper deployment of spacers. Furthermore, patients undergoing radiation therapy with hydrogel-based spacers are lesser prone to adverse long-term rectal complications and relatively decreased amount of rectal pain during treatment, making hydrogel-based spacer most sought-after among oncologists.
Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/8507
Cancer specialists are constantly shifting towards absorbable tissue spacer to cure different types of cancers. Absorbable tissue spacers, after proper placement, protects the adjacent healthy tissues from strong radiation, resulting in increased concentration of dose delivery at the affected organ, thereby eliminating adverse procedural events. Further, absorbable tissue spacers avoid the need for a second surgery for spacer removal as they gradually dissolve into the tissues.
The market for absorbable tissue spacer is still young, and this study tracks the growth of absorbable tissue spacers market over the period of next decade. The study unfolds how increasing investments of stakeholders in clinical trials of newly innovated absorbable tissue spacers will contribute towards the progress of the market. Although Europe was the only region driving the growth of absorbable tissue spacers market till a couple of years ago, FMI attempts to analyze how the penetration will increase in other regional markets over the course of next decade.
About Us
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Contact Us
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44 (0) 20 7692 8790
Sales: sales@futuremarketinsights.com
Future Market Insights (FMI), in its latest research study, examines the absorbable tissue spacer market and presents actionable insights on its progress over the evaluation timespan of 2019-2029. As per the research study, the global absorbable tissue spacer market reached ~US$ 85 Mn in terms of value in 2018, and is expected to propel at an impressive CAGR of ~10 % during the forecast period. Increasing emphasis of medical and healthcare industry operators on patient safety offers a strong impetus to the growth of absorbable tissue market, concludes FMI’s analysis.
Surging demand for radiation therapy in the backdrop of rising morbidities due to cancers as compared to other chronic diseases altogether in developed and under-developed economies are surfacing as the cornerstone for the progress of absorbable tissue spacer market, says the FMI study. Furthermore, stringent legal policies will persist to regulate the emission of high-energy rays during radiotherapy treatment and assure patient safety, which is likely to motivate manufacturers to perform clinical studies by consulting with experts.
Increasing prevalence of cancers continues to be a global concern, and elimination of cancerous tissues in an efficient way remains of core interest for oncologists and dosimetrists. The leading participants in absorbable tissue spacers market landscape are focusing on conducting clinical trials to develop spacers that are tailored to specific needs of the target area.
Request a report sample to obtain authentic analysis and comprehensive market insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8507
Hydrogel-based Spacer Remains Preferred among Surgeons
As per the findings of FMI’s research, hydrogel-based absorbable tissue spacers account for ~3/4th shares of total sales. The report further suggests that the hydrogel-based spacer is rapidly becoming an integral component of prostate cancer radiotherapy and is one of the few absorbable tissue spacers that have received government clearance in most of the countries.
Hydrogel-based spacers have high tolerability as the space created between prostate and rectum efficiently lowers the emission concentration on the rectum, significantly reducing irritation of rectum during prostate radiotherapy. Placing hydrogel-based spacers is technically less-complicated, especially for surgeons who are aware of ultrasound-directed transperineal injections. Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans enable confirmation about proper deployment of spacers. Furthermore, patients undergoing radiation therapy with hydrogel-based spacers are lesser prone to adverse long-term rectal complications and relatively decreased amount of rectal pain during treatment, making hydrogel-based spacer most sought-after among oncologists.
Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/8507
Cancer specialists are constantly shifting towards absorbable tissue spacer to cure different types of cancers. Absorbable tissue spacers, after proper placement, protects the adjacent healthy tissues from strong radiation, resulting in increased concentration of dose delivery at the affected organ, thereby eliminating adverse procedural events. Further, absorbable tissue spacers avoid the need for a second surgery for spacer removal as they gradually dissolve into the tissues.
The market for absorbable tissue spacer is still young, and this study tracks the growth of absorbable tissue spacers market over the period of next decade. The study unfolds how increasing investments of stakeholders in clinical trials of newly innovated absorbable tissue spacers will contribute towards the progress of the market. Although Europe was the only region driving the growth of absorbable tissue spacers market till a couple of years ago, FMI attempts to analyze how the penetration will increase in other regional markets over the course of next decade.
About Us
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Contact Us
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44 (0) 20 7692 8790
Sales: sales@futuremarketinsights.com
